Connection
Shiv Kumar Agarwal to Diabetes Mellitus, Type 1
This is a "connection" page, showing publications Shiv Kumar Agarwal has written about Diabetes Mellitus, Type 1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
6.785 |
|
|
|
-
Agarwal S, Mathias P, Schechter C, Finnan M, Greenberg M, Leung SL, Movsas S, Long JA. The Supporting Emerging Adults With Diabetes (SEAD) Program: An Adult-Based Real-World Clinical Model That Improves Hospitalizations, Diabetes Technology Uptake, and Glycemic Outcomes in Underserved Young Adults With Type 1 Diabetes. Diabetes Care. 2024 Nov 01; 47(11):1995-2001.
Score: 0.755
-
Mathias P, Corathers SD, Carreon SA, Hilliard ME, Papadakis JL, Weissberg-Benchell J, Raymond JK, Pyatak EA, Agarwal S. Young Adults with Type 1 Diabetes. Endocrinol Metab Clin North Am. 2024 Mar; 53(1):39-52.
Score: 0.703
-
Agarwal S, Rioles N, Majidi S, Rapaport R, Ebekozien O. Commentary on the T1D exchange quality improvement collaborative learning session November 2022 abstracts. J Diabetes. 2022 11; 14(11):780-782.
Score: 0.657
-
Mathias P, Mahali LP, Agarwal S. Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors. Diabetes Care. 2022 10 01; 45(10):2231-2237.
Score: 0.653
-
Agarwal S, Crespo-Ramos G, Leung SL, Finnan M, Park T, McCurdy K, Gonzalez JS, Long JA. Solutions to Address Inequity in Diabetes Technology Use in Type 1 Diabetes: Results from Multidisciplinary Stakeholder Co-creation Workshops. Diabetes Technol Ther. 2022 06; 24(6):381-389.
Score: 0.638
-
Agarwal S, Simmonds I, Myers AK. The Use of Diabetes Technology to Address Inequity in Health Outcomes: Limitations and Opportunities. Curr Diab Rep. 2022 07; 22(7):275-281.
Score: 0.638
-
Agarwal S, Crespo-Ramos G, Long JA, Miller VA. "I Didn't Really Have a Choice": Qualitative Analysis of Racial-Ethnic Disparities in Diabetes Technology Use Among Young Adults with Type 1 Diabetes. Diabetes Technol Ther. 2021 09; 23(9):616-622.
Score: 0.606
-
Agarwal S, Raymond JK, Schutta MH, Cardillo S, Miller VA, Long JA. An Adult Health Care-Based Pediatric to Adult Transition Program for Emerging Adults With Type 1 Diabetes. Diabetes Educ. 2017 02; 43(1):87-96.
Score: 0.435
-
Straton E, Bryant BL, Kang L, Wang C, Barber J, Perkins A, Gallant L, Marks B, Agarwal S, Majidi S, Monaghan M, Streisand R. ROUTE-T1D: A behavioral intervention to promote optimal continuous glucose monitor use among racially minoritized youth with type 1 diabetes: Design and development. Contemp Clin Trials. 2024 05; 140:107493.
Score: 0.180
-
Yayah Jones NH, Cole I, Hart KJ, Corathers S, Agarwal S, Odugbesan O, Ebekozien O, Kamboj MK, Harris MA, Fantasia KL, Mansour M. Social Determinants of Health Screening in Type 1 Diabetes Management. Endocrinol Metab Clin North Am. 2024 Mar; 53(1):93-106.
Score: 0.176
-
Hoogendoorn CJ, Hernandez R, Schneider S, Harmel M, Pham LT, Crespo-Ramos G, Agarwal S, Crandall J, Peters AL, Spruijt-Metz D, Gonzalez JS, Pyatak EA. Glycemic Risk Index Profiles and Predictors Among Diverse Adults With Type 1 Diabetes. J Diabetes Sci Technol. 2024 Sep; 18(5):1070-1078.
Score: 0.169
-
Gregory JW, Cameron FJ, Joshi K, Eiswirth M, Garrett C, Garvey K, Agarwal S, Codner E. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes in adolescence. Pediatr Diabetes. 2022 11; 23(7):857-871.
Score: 0.164
-
Odugbesan O, Addala A, Nelson G, Hopkins R, Cossen K, Schmitt J, Indyk J, Jones NY, Agarwal S, Rompicherla S, Ebekozien O. Implicit Racial-Ethnic and Insurance-Mediated Bias to Recommending Diabetes Technology: Insights from T1D Exchange Multicenter Pediatric and Adult Diabetes Provider Cohort. Diabetes Technol Ther. 2022 09; 24(9):619-627.
Score: 0.160
-
Ebekozien O, Mungmode A, Odugbesan O, Majidi S, Prahalad P, Noor N, Rioles N, Agarwal S, Weinstock RS, Rapaport R, Kamboj M. Addressing type 1 diabetes health inequities in the United States: Approaches from the T1D Exchange QI Collaborative. J Diabetes. 2022 Jan; 14(1):79-82.
Score: 0.154
-
Akturk HK, Agarwal S, Hoffecker L, Shah VN. Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards. Diabetes Care. 2021 06; 44(6):e121-e123.
Score: 0.149
-
Polsky S, Foster NC, DuBose SN, Agarwal S, Lyons S, Peters AL, Uwaifo GI, DiMeglio LA, Sherr JL, Levy CJ. Incident diabetes complications among women with type 1 diabetes based on parity. J Matern Fetal Neonatal Med. 2022 Dec; 35(24):4629-4634.
Score: 0.144
-
Kahkoska AR, Nguyen CT, Jiang X, Adair LA, Agarwal S, Aiello AE, Burger KS, Buse JB, Dabelea D, Dolan LM, Imperatore G, Lawrence JM, Marcovina S, Pihoker C, Reboussin BA, Sauder KA, Kosorok MR, Mayer-Davis EJ. Characterizing the weight-glycemia phenotypes of type 1 diabetes in youth and young adulthood. BMJ Open Diabetes Res Care. 2020 01; 8(1).
Score: 0.135
-
Haymond MW, DuBose SN, Rickels MR, Wolpert H, Shah VN, Sherr JL, Weinstock RS, Agarwal S, Verdejo AS, Cummins MJ, Newswanger B, Beck RW. Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes. J Clin Endocrinol Metab. 2017 08 01; 102(8):2994-3001.
Score: 0.114
-
Garvey KC, Foster NC, Agarwal S, DiMeglio LA, Anderson BJ, Corathers SD, Desimone ME, Libman IM, Lyons SK, Peters AL, Raymond JK, Laffel LM. Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes. Diabetes Care. 2017 Mar; 40(3):317-324.
Score: 0.109
-
Wallia A, Agarwal S, Owen AL, Lam EL, Davis K, Bailey SC, DeLacey SE, Pack AP, Espinoza J, Bright D, Eggleston A, Walter E, O'Brien MJ. Disparities in Continuous Glucose Monitoring Among Patients Receiving Care in Federally Qualified Health Centers. JAMA Netw Open. 2024 Nov 04; 7(11):e2445316.
Score: 0.047
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|